Heart failure device study aims to boost response rates
NCT ID NCT03280862
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 29 times
Summary
This study tests whether placing the left ventricle lead of a heart device at the area with the latest electrical activation improves outcomes for people with heart failure and a wide QRS. About 1000 participants will be randomly assigned to either targeted or standard lead placement. The goal is to see if this approach reduces death or unplanned hospital stays for heart failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aalborg University Hospital
Aalborg, 9000, Denmark
-
Aarhus University Hospital
Aarhus, 8200, Denmark
-
Gentofte University Hospital
Gentofte Municipality, 2900, Denmark
-
Odense University Hospital
Odense, 5000, Denmark
-
Rigshospitalet
Copenhagen, 2100, Denmark
Conditions
Explore the condition pages connected to this study.